Physician profile
Meredith Overholt
NPI 1801949151
$21,430.81
in general payments reported to CMS, 2019-2025
29 companies · $2,157 in 2025
The $2,157 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $925 · 2021: $526 · 2022: $4,267 · 2023: $7,785 · 2024: $5,006 · 2025: $2,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $3,024 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,824.89 |
| Food and Beverage | $3,024.20 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13,675.31 | 2019-2025 | |
| Allergan, INC. | $3,203.59 | 2019-2022 | |
| Merz North America, INC. | $750.06 | 2019-2025 | |
| Galderma Laboratories, L.P. | $446.34 | 2022-2025 | Nemluvio, Aklief |
| Janssen Biotech, INC. | $429.32 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| E.R. Squibb & Sons, L.L.C. | $369.75 | 2022-2025 | Sotyktu |
| Leo Pharma INC. | $327.17 | 2019-2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $266.81 | 2019-2025 | |
| Ucb, INC. | $239.27 | 2019-2024 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $223.89 | 2020-2024 | Absorica Ld, Winlevi |
| Arcutis Biotherapeutics, INC. | $179.44 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $173.61 | 2019-2023 | Dupixent |
| Genzyme Corporation | $169.86 | 2020-2022 | |
| Amgen INC. | $164.94 | 2020-2025 | Otezla, Otezla |
| Janssen Scientific Affairs, LLC | $147.80 | 2023 | Tremfya |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $117.01 | 2019-2023 | |
| Revance Therapeutics, INC. | $107.92 | 2024-2025 | Daxxify |
| Biowound Solutions, INC. | $73.36 | 2025 | Bio-Connekt |
| Genentech USA, INC. | $68.93 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $56.00 | 2019-2022 | |
| Epi Health, LLC | $45.20 | 2020-2021 | |
| Incyte Corporation | $35.74 | 2022-2025 | Opzelura |
| Mayne Pharma Commercial LLC | $28.20 | 2024 | |
| Kyowa Kirin, INC. | $26.44 | 2025 | |
| Lilly USA, LLC | $26.33 | 2022-2023 | Taltz, Olumiant |
| Almirall LLC | $24.81 | 2020 | |
| Dermavant Sciences, INC. | $23.32 | 2024 | Vtama |
| Biofrontera INC. | $16.85 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Verrica Pharmaceuticals INC. | $13.54 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Overholt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.